Figure 2: Time to discontinuation of abiraterone acetate.
A: Time to discontinuation of abiraterone acetate (n=170)
B: Time to discontinuation of abiraterone acetate in patients with primary resistance (n=44) versus no resistance (n=126)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.